These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 3321082

  • 1. Japanese gamma globulin trials for Kawasaki disease.
    Furusho K, Kamiya T, Nakano H, Kiyosawa N, Shinomiya K, Hayashidera T, Tamura T, Hirose O, Manabe Y, Yokoyama T.
    Prog Clin Biol Res; 1987; 250():425-32. PubMed ID: 3321082
    [No Abstract] [Full Text] [Related]

  • 2. Intravenous gamma globulin therapy in Kawasaki disease--trial of low dose gamma globulin.
    Okuni M, Harada K, Yamaguchi H, Yanagawa H, Sonobe T, Kawasaki T.
    Prog Clin Biol Res; 1987; 250():433-9. PubMed ID: 3321083
    [No Abstract] [Full Text] [Related]

  • 3. Clinical evaluation of gammaglobulin preparations for the treatment of Kawasaki disease.
    Ogino H, Ogawa M, Harima Y, Kono S, Ohkuni H, Nishida M, Kobayashi Y, Yabuuchi H.
    Prog Clin Biol Res; 1987; 250():555-6. PubMed ID: 3321085
    [No Abstract] [Full Text] [Related]

  • 4. U.S. gamma globulin trial.
    Newburger JW.
    Prog Clin Biol Res; 1987; 250():441-3. PubMed ID: 3321084
    [No Abstract] [Full Text] [Related]

  • 5. Can consensus be reached in cardiac management of Kawasaki syndrome? Review of a survey among Japanese and U.S. pediatric cardiologists.
    Takahashi M, Kato H.
    Prog Clin Biol Res; 1987; 250():493-508. PubMed ID: 3423056
    [No Abstract] [Full Text] [Related]

  • 6. The treatment of Kawasaki syndrome with intravenous gamma globulin.
    Newburger JW, Takahashi M, Burns JC, Beiser AS, Chung KJ, Duffy CE, Glode MP, Mason WH, Reddy V, Sanders SP.
    N Engl J Med; 1986 Aug 07; 315(6):341-7. PubMed ID: 2426590
    [Abstract] [Full Text] [Related]

  • 7. Can early treatment provide better prognosis in Kawasaki disease? A retrospective study on 616 children.
    Usami H, Harada K, Okuni M.
    Prog Clin Biol Res; 1987 Aug 07; 250():577-8. PubMed ID: 3423079
    [No Abstract] [Full Text] [Related]

  • 8. Selection of high-risk children for immunoglobulin therapy in Kawasaki disease.
    Iwasa M, Sugiyama K, Ando T, Nomura H, Katoh T, Wada Y.
    Prog Clin Biol Res; 1987 Aug 07; 250():543-4. PubMed ID: 3423068
    [No Abstract] [Full Text] [Related]

  • 9. Treatment of Kawasaki disease.
    Nakashima L, Edwards DL.
    Clin Pharm; 1990 Oct 07; 9(10):755-62. PubMed ID: 2242655
    [Abstract] [Full Text] [Related]

  • 10. Enzyme release and O2 production of neutrophils and vascular lesions in gamma globulin therapy of Kawasaki disease.
    Okazaki T, Sakatani T, Sasagawa S, Ohta H, Ohnishi H, Suzuki K.
    Prog Clin Biol Res; 1987 Oct 07; 250():557-8. PubMed ID: 3423073
    [No Abstract] [Full Text] [Related]

  • 11. Efficacies and risks of aspirin in the treatment of the Kawasaki disease.
    Kusakawa S, Tatara K.
    Prog Clin Biol Res; 1987 Oct 07; 250():401-13. PubMed ID: 3423052
    [No Abstract] [Full Text] [Related]

  • 12. High-dose gammaglobulin therapy for Kawasaki disease.
    Nagashima M, Matsushima M, Matsuoka H, Ogawa A, Okumura N.
    J Pediatr; 1987 May 07; 110(5):710-2. PubMed ID: 2437278
    [Abstract] [Full Text] [Related]

  • 13. Effect of liposomal encapsulated superoxide dismutase on patients with Kawasaki disease.
    Somiya K, Niwa Y, Fukami S, Michelson AM.
    Prog Clin Biol Res; 1987 May 07; 250():573-5. PubMed ID: 3423078
    [No Abstract] [Full Text] [Related]

  • 14. Kawasaki disease in Nebraska: a review of the literature.
    Cheatham JP, Kugler JD, Pinsky WW, Hofschire PJ.
    Nebr Med J; 1983 Sep 07; 68(9):282-93. PubMed ID: 6355872
    [No Abstract] [Full Text] [Related]

  • 15. High-dose intravenous gamma-globulin therapy in Kawasaki disease.
    Hwang BT, Lin CY, Hsieh KS, Tsuei DH, Meng CC.
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1989 Sep 07; 30(1):15-22. PubMed ID: 2484055
    [Abstract] [Full Text] [Related]

  • 16. Clinical and immunologic aspects of Kawasaki disease.
    Leung DY.
    Immunodefic Rev; 1989 Sep 07; 1(3):261-71. PubMed ID: 2698643
    [Abstract] [Full Text] [Related]

  • 17. [Treatment of Kawasaki syndrome by intravenous gamma globulins. A medium-term clinical and paraclinical study of 5 cases].
    Lebranchu Y, Despert F, Borderon JC, Bloc D, Renoux M, Bardos P, Laugier J.
    Ann Pediatr (Paris); 1986 Nov 07; 33(9):809-13. PubMed ID: 3492169
    [No Abstract] [Full Text] [Related]

  • 18. Kawasaki disease.
    Shulman ST, Bendet M.
    Compr Ther; 1997 Jan 07; 23(1):13-8. PubMed ID: 9067077
    [No Abstract] [Full Text] [Related]

  • 19. Kawasaki disease: management guidelines.
    Nieves-Rivera F, Martin Pumarejo M, Villavicencio R.
    Bol Asoc Med P R; 1988 Feb 07; 80(2):51-3. PubMed ID: 2450550
    [No Abstract] [Full Text] [Related]

  • 20. High-dose intravenous gammaglobulin for Kawasaki disease.
    Furusho K, Kamiya T, Nakano H, Kiyosawa N, Shinomiya K, Hayashidera T, Tamura T, Hirose O, Manabe Y, Yokoyama T.
    Lancet; 1984 Nov 10; 2(8411):1055-8. PubMed ID: 6209513
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.